Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Sorafenib for Medullary Thyroid Cancer
Recruiting1 awardPhase 2
Columbus, Ohio
This trial looks at how well a drug called sorafenib tosylate works in treating patients with thyroid cancer that has spread or returned. The drug may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.